Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis
Oct 03, 2023•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis".
Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000
For the best experience, listen in Metacast app for iOS or Android